Controlled-release CNP agonists with low initial NPR-B activity

• 收藏
• 分享

专利权人:

Ascendis Pharma Growth Disorders A/S

发明人:

Sprogøe, Kennett,Rau, Harald,Cleemann, Felix,Hersel, Ulrich,Rasmussen, Caroline Elisabeth

申请号：

AU2017205693

公开号：

AU2017205693A1

申请日:

2017.01.05

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention relates to a controlled-release CNP agonist from which CNP agonist is released with a release half-life of at least 6 hours under physiological conditions and which controlled-release CNP agonist has an EC

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/